Evaluating the cost-effectiveness of respiratory syncytial virus vaccination among risk-stratified older adults. Hutton DW, Prosser LA, Ortega-Sanchez IR, Leidner AJ, et al. Vaccine 2026;90:129023.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hutton DW, Prosser LA, Ortega-Sanchez IR, Leidner AJ, et al. Evaluating the cost-effectiveness of respiratory syncytial virus vaccination among risk-stratified older adults. Vaccine 2026;90:129023.
PMID: 42571751